Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Dec 3.
Published in final edited form as: Phys Med Biol. 2024 Dec 3;69(24):10.1088/1361-6560/ad95d6. doi: 10.1088/1361-6560/ad95d6

Feasibility Study of Modularized Pin Ridge Filter Implementation in Proton FLASH Planning for Liver Stereotactic Ablative Body Radiotherapy

Chaoqiong Ma 1,2, Xiaofeng Yang 1,*, Jufri Setianegara 2, Yinan Wang 1, Yuan Gao 1, David Yu 1, Pretesh Patel 1, Jun Zhou 1,*
PMCID: PMC11653111  NIHMSID: NIHMS2039809  PMID: 39571283

Abstract

Objective.

We previously developed a FLASH planning framework for streamlined pin-ridge-filter (pin-RF) design, demonstrating its feasibility for single-energy proton FLASH planning. In this study, we refined the pin-RF design for easy assembly using reusable modules, focusing on its application in liver stereotactic ablative body radiotherapy (SABR).

Approach.

This framework generates an intermediate intensity-modulated proton therapy (IMPT) plan and translates it into step widths and thicknesses of pin-RFs for a single-energy FLASH plan. Parameters like energy spacing, monitor unit limit, and spot quantity were adjusted during IMPT planning, resulting in pin-RFs assembled using predefined modules with widths from 1 to 6 mm, each with a water-equivalent-thickness of 5 mm. This approach was validated on three liver SABR cases. FLASH doses, quantified using the FLASH effectiveness model at 1 to 5 Gy thresholds, were compared to conventional IMPT (IMPT-CONV) doses to assess clinical benefits.

Main results.

The highest demand for 6 mm width modules, moderate for 2–4 mm, and minimal for 1- and 5-mm modules were shown across all cases. At lower dose thresholds, the two-beam case reduced indicators including liver V21Gy and skin Dmax by >19.4%, while the three-beam cases showed reductions ≤11.4%, indicating the need for higher fractional beam doses for an enhanced FLASH effect. Positive clinical benefits were seen only in the two-beam case at the 5 Gy threshold. At the 1 Gy threshold, the two-beam FLASH plan outperformed the IMPT-CONV plan, reducing dose indicators for all relevant normal tissues by up to 31.2%. In contrast, the three-beam cases showed negative clinical benefits, with skin Dmax and liver V21Gy increasing by up to 17.4% due to lower fractional beam doses and closer beam arrangements.

Significance.

This study evaluated the feasibility of modularizing streamlined pin-RFs in single-energy proton FLASH planning for liver SABR, offering guidance on optimal module composition and strategies to enhance FLASH planning.

Keywords: Proton FLASH, Modularized ridge filter, Liver SABR

1. Introduction

FLASH radiotherapy (FLASH-RT), employing ultrahigh-dose-rate irradiation typically exceeding 40 Gy/s, has emerged as a promising approach for reducing toxicity in healthy tissues while effectively maintaining tumor control, surpassing conventional-dose-rate irradiation.(Favaudon et al 2014, Vozenin et al 2019, Fouillade et al 2020, Bourhis et al 2019a) Through the use of proton, electron, or photon beams at ultrahigh dose rates, small animal studies have demonstrated significant protective effects on normal structures such as the lungs, brain, skin, and abdominal tissues,(Favaudon et al 2014, Vozenin et al 2019, Loo et al 2017, Montay-Gruel et al 2019, 2017) suggesting a potential for broad application in sparing healthy tissues during cancer treatment. The underlying mechanisms of FLASH-RT, potentially linked to oxygen depletion and the production of reactive oxygen species, continue to be a focal point of ongoing research investigations.(Wilson et al 2020, Spitz et al 2019) The clinical utility of FLASH-RT was initially confirmed in a patient with T-cell cutaneous lymphoma, where electron beam treatment improved outcomes for both the tumor and surrounding skin.(Bourhis et al 2019b) Further clinical validation was provided by the FAST-01 trial, which demonstrated the efficacy of proton-based FLASH-RT in patients with multiple bone metastases.(Mascia et al 2023, Daugherty et al 2023) Ongoing trials continue to explore the use of proton therapy for chest bone metastases(Daugherty et al 2024) and electron therapy for metastatic skin melanoma,(Anon n.d.) underpinning the expanding therapeutic scope of FLASH-RT.

Benefiting from the narrow Bragg peaks (BPs), proton beams offer superior precision in tumor targeting and normal tissue sparing when compared with photon and electron beams. This precision is enhanced by the widely used delivery method of pencil beam scanning (PBS) for intensity-modulated proton therapy (IMPT), which ensures high dose conformity to the target.(Newhauser and Zhang 2015) These attributes, coupled with the extensive treatment range of proton beams, establish them as the preferred modality for FLASH-RT. However, delivering proton beams at FLASH dose rates using a clinical cyclotron presents challenges due to the modulation of proton energies by an energy degrader and energy selection system, required to achieve spread-out Bragg peaks (SOBPs) for PBS-IMPT, significantly reducing beam current and impeding FLASH rate delivery.(Jolly et al 2020) To address this issue, preliminary studies have explored using the highest energy proton transmission beams (TBs) from a cyclotron for FLASH planning, utilizing the entrance dose region of the Bragg curves for target dose coverage while placing the BPs outside the patient.(Gao et al 2020, van de Water et al 2019, van Marlen et al 2020, Folkerts et al 2020) This method, however, risks increased exposure of normal tissue at the distal edge of the target to high exit dose of TBs. To overcome this, strategies have been developed to use the BPs of the highest energy for direct target coverage in FLASH planning, in which range compensators are customized to align the single-energy BPs to the distal edge of the target.(Wei et al 2022c, 2022b, Kang et al 2022) Additionally, efforts have been made to integrate BPs of conventional dose rates,(Lin et al 2021) or single-energy SOBPs created by shooting the highest energy proton beams through general bar ridge filters (RFs),(Ma et al 2023) with TBs for FLASH planning.

To maximize the utility of BPs in FLASH-RT, studies has focused on the use of pin-shaped RFs (pin-RFs), which consist of step-shaped ridge pins designed to produce a single-energy SOBP along each pencil beam direction (PBD) for IMPT-PBS.(Simeonov et al 2017, Schwarz et al 2022, Liu et al 2023, Zhang et al 2022a) These pin-RFs are tailored primarily in two ways for single-energy proton FLASH planning. The first approach involves designing the step widths and thicknesses of each ridge pin to create a uniform SOBP that conforms to the target along the corresponding PBD, proving feasible for FLASH therapy by simultaneously accounting for dose, dose rate coverage, and linear energy transfer (LET) effects.(Simeonov et al 2017, Schwarz et al 2022, Liu et al 2023) Alternatively, ridge pins can be configured to modulate the dose distribution along each PBD in a manner similar to traditional PBS-IMPT, allowing for more flexible manipulation of dose distributions.(Zhang et al 2022a) However, these pin-RF designs typically feature more than 10 steps per pin with a fine resolution of 0.1 mm, necessitating a high-precision and time-intensive production process, such as 3D printing. Building on the second design technique, a streamlined pin-RF design method was developed in our previous study, creating pin-RFs with coarser resolution suitable for FLASH planning.(Ma et al 2024) This innovation potentially allows for more efficient production, the possibility of assembling with reusable modules, and thus offers flexible adjustability and reduced production costs for the pin-RFs.

Proton stereotactic ablative body radiotherapy (SABR) has demonstrated superior prognostic outcomes in the treatment of liver cancer.(Nabavizadeh et al 2018) With the integration of FLASH delivery, proton SABR for liver cancers offers the potential to reduce normal tissue toxicities thereby enhancing therapeutic efficacy.(Levy et al 2020) Leveraging our previously developed FLASH planning framework for streamlined pin-RF design, this study aimed to further refine the streamlined pin-RF design and explore its modularization using reusable modules. We specifically focused on applying this approach to FLASH planning for liver SABR, with the goal of assessing the achievable FLASH effect using this refined planning strategy.

2. Methods and materials

The following subsections begins with an overview of our in-house FLASH planning framework for the streamlined pin-RF design, and its implementation in this study. Following this, we elaborate on the modularization strategy for the streamlined pin-RFs, highlighting the selection of specific parameters in the FLASH planning framework and the design of reusable unit modules for efficient pin-RF assembly. In the context of implementing these modularized pin-RFs for liver SABR FLASH planning, we further provide details on adopting FLASH effectiveness model to assess the FLASH effect of the FLASH plans for the liver cases.

2.1. Streamlined pin-RF design for FLASH planning

Previously, we proposed a streamlined pin-RF designing approach for single-energy proton FLASH planning (Ma et al 2024). A flowchart of this FLASH planning framework is depicted in Figure 1(a). This method is based on the concept of converting pin-RFs from an IMPT plan,(Zhang et al 2022b) where each pyramid-shaped ridge pin featuring variable step thicknesses and surface areas is used to modulate the depth dose curve of a monoenergetic proton beam along a specific PBD to replicate the depth dose curve along the same PBD in the IMPT plan. Figure 1(b) displays the front and top views of a four-step ridge pin. The water equivalent thickness (WET), Ti, of step i (i >1) in a ridge pin, can be calculated from the BP depths, Ri and Ri-1, of the ith and (i-1)th highest energies, respectively, along the corresponding PBD in the IMPT plan, using equation (1). And WET of the bottom step can be derived the using equation (2), which factors in the WETs of the pin-RF base and the range shifter (RS), TRS and TB, respectively, for the given field. Figure 1(c) represents a two-field setup of the pin-RFs and RSs for a liver case, where the RS associated with each field serves to pull up the BPs of the highest energy beam with a range of R0 (e.g., 250 MeV of a Varian ProBeam at our facility) to the distal edge of the target, thus allowing the corresponding pin-RF to spread out the BPs within the target. The step width, Li, of step i can be derived using equations (3) and (4), accounting for the relative weight, w¯i, of the ith highest energy among all the N energies along the PBD in the IMPT plan, where wi denotes the weight of the ith highest energy along this PBD.

Figure 1.

Figure 1.

(a) Flowchart of the FLASH planning framework. (b) Front and top views of a four-step ridge pin. T2 and L2 are the thickness and width of the second step from the bottom, respectively. (c) A two-field arrangement for a single-energy proton FLASH plan using designed pin ridge filters, with a 3D view of one pin RF. The target is outlined in blue.

Ti=RiRi1 (1)
T1=R0TRSTB (2)
w¯i=wi/i=1Nwi (3)
w¯i=(Li12Li2)/L12 (4)

To design the streamlined pin-RFs featuring a coarse resolution and sparse pin distribution, we established an inverse planning framework (Figure 1(a)) which is integrated within a Treatment Planning System (TPS), RayStation 10B (RaySearch Laboratories, Stockholm, Sweden), for FLASH planning (Ma et al 2024). This framework initiates by creating an IMPT plan which incorporates multiple energy layers generated through a downstream energy modulation strategy, referred to as IMPT-DS plan. It then proceeds with a nested pencil-beam-direction-based (PBD-based) spot reduction process to iteratively eliminate the low-weighted energy layers along each PBD and low-weighted PBDs from the IMPT-DS plan. Subsequently, the IMPT-DS plan is translated into the pin-RFs and the single-energy beam configurations, including spot positions and weights, for the FLASH plan (referred to as IMPT-RF). The pin-RFs produced through this approach are characterized by fewer ridge pins and reduced steps along each pin, facilitating efficient production.

In this study, we implemented this FLASH planning framework for liver SABR cases. Shifting from the use of PMMA in our previous study, we adopted graphite as the material for RSs, a common material used for energy degraders due to its reasonably low atomic number (Z = 6), good mechanical robustness, and cost-effectiveness.(Psoroulas et al 2020) Compared to PMMA, graphite exhibits a lower multiple Coulomb scattering (MCS) effect of protons. Furthermore, the higher relative stopping power (RSP) to water of graphite, compared to PMMA (1.68 vs. 1.17), allows for an over 40% reduction in the WET of the RS. This reduction can shorten the distance from the pin-RF to the isocenter (RF-to-iso), consequently diminishing the inverse square effect and enhancing the dose conformity of the IMPT-RF. By switching to graphite as the RS material, we were able to reduce the RF-to-iso distance from 31 cm to 26 cm in this study.

2.2. Modularization of the pin-RFs

The primary goal of this study is to produce the streamlined pin-RFs of pyramid-shaped ridge pins for liver SABR FLASH planning through a modular strategy. This involves assembling the pin-RFs with cuboid-shaped unit modules that have specified widths and WETs, chosen from a predetermined collection of reusable modules. As mentioned earlier, these pin-RFs are translated from an IMPT-DS plan in our FLASH planning process. Thus, the resolution and sparsity of the ridge pins, which determine the shapes and quantities of the required unit modules for assembly, respectively, can be adjusted through the parameter settings applied in this intermediate IMPT planning.

The resolution of the pyramid-shaped ridge pin is defined by the WET and width resolutions of the steps. The WET of each step indicates the variation in BP depths between two successive energies along the PBD in the corresponding IMPT-DS plan. Thus, the minimum WET across the steps of the ridge pin, reflecting the WET resolution of the ridge pin, matches the energy layer spacing adopted in the planning process for the IMPT-DS plan. This necessitates that the WET of the cuboid unit modules to assemble the ridge pins aligns with this minimum step WET. In this study, the energy layer spacing in the planning for the IMPT-DS plan was set to 5 mm, resulting in the WETs of the unit modules featuring a 5 mm resolution. In addition, the step width resolution of 1 mm of the ridge pin was aligned with that of the streamlined pin-RF from our previous implementation of the FLASH planning framework. Attaining this coarse resolution necessitates a strategic reduction in the number of steps per ridge pin, facilitated by the nested PBD-based spot reduction process in IMPT planning. This process is essential due to the step widths of a ridge pin are calculated from the spot weights along the corresponding PBD of the IMPT-DS plan, as outlined in equations (3) and (4). This is followed by rounding the calculated step widths to the nearest whole millimeter. A thorough explanation of achieving this resolution is provided in our previous study.(Ma et al 2024) Given that the bottom step width, L1, of a ridge pin is 6 mm, we designed the unit modules in six specific widths, ranging from 1 to 6 mm in 1 mm increments. Consequently, this module set comprises of unit modules in six distinct sizes, each featuring a WET of 5 mm and widths ranging from 1 to 6 mm, in 1 mm intervals, as depicted in Figure 2. This design allows for the assembly of any step of a pin-RF by stacking unit modules with the same width as the step.

Figure 2.

Figure 2.

Unit modules of six sizes

Furthermore, reducing the total number of ridge pins is essential for efficiently assembling the pin-RFs. This can be accomplished by eliminating the low-weighted PBDs with total spot monitor units (MUs) below a predefined threshold during the nested PBD-based spot reduction process in the IMPT-DS planning. It is important to note that the spot MU for a PBD of the translated IMPT-RF corresponds to the cumulative spot MUs for that PBD in the IMPT plan. Therefore, this MU threshold should be sufficiently high to allow the minimum spot weight of the IMPT-RF to be deliverable at a high beam current, necessary for achieving FLASH dose rates. In this study, the MU threshold was set to 300 MU, ensuring the deliverability of the IMPT-RF at a beam current of 500 nA and a minimum spot duration time of 0.5 ms.

2.3. Patient study

This modularized pin-RF design for FLASH planning was validated on three liver cancer patients previously underwent conventional IMPT. For each patient, an IMPT-RF plan employing the modularized pin-RFs was generated. The sizes of clinical target volume (CTV) for Patient/Case 1, 2 and 3 were 48.9, 65.4 and 125.7 cc, respectively. The prescription dose was set to 50 Gy delivered in five fractions in accordance with our clinical liver SABR guidelines. To ensure target dose conformity and avoidance of the normal tissues, the beam angles from the original conventional IMPT plans (IMPT-CONV) were maintained in the FLASH planning: two beams for patient 1, and three beams for patient 2 and 3. The objective for CTV coverage was that 95% of the CTV receives the full prescription dose, D95% = 50 Gy. Additionally, the maximum dose, Dmax, of the CTV was limited to 140% of the prescription dose (Dmax ≤ 70 Gy). Robust optimization was incorporated into the IMPT-DS planning of the FLASH planning process, accommodating setup and range uncertainties of 5 mm and 3.5%, in alignment with our clinical protocol guidelines. Besides, single-field optimization (SFO) was utilized to achieve robust uniform field doses.

The quality of the IMPT-RF plan was assessed based on the concerned dose indicators for the normal tissues and the target dose conformity. The latter was quantified using the conformity index (CI), calculated as the ratio of the total volume that received the prescription dose to the CTV volume. Additionally, a robustness analysis was conducted for each IMPT-DS plan, which included 12 perturbation scenarios accounting for setup uncertainties in all three directions, along with a ±3.5% range uncertainty. Each scenario combined a setup error in one direction with a single-sign range uncertainty.

2.4. Evaluation of FLASH effect

The FLASH dose of the IMPT-RF plan was quantified using the FLASH effectiveness model.(Krieger et al 2022) This model operates on the principle that the FLASH effect is triggered in a normal tissue voxel if the dose (Δd) delivered within a time window (Δt) exceeds a dose threshold (D0), ΔdD0 and is delivered at an average dose rate surpasses a dose rate threshold (D˙0),Δd/ΔtD˙0. This FLASH effect remains active throughout the triggering window and an additional persistence period. The dose delivered with the FLASH effect is deemed biologically less “effective”, and therefore, it is adjusted by an effective factor (<1), reflecting reduced toxicity.(Mazal et al 2020)

In this work, D˙0, persistence time and effective factor were set to 40 Gy/s, 200 ms and 0.67, respectively, mirroring the values from the aforementioned study.(Krieger et al 2022) The effective factor of 0.67 represents a 33% reduction in the dose delivered to normal tissues via active FLASH effect. Given the significant dependency of the FLASH effect on D0, as demonstrated in the previous study,(Krieger et al 2022) D0 of 1, 3 and 5 Gy were selected to evaluate the FLASH effective doses for each FLASH plan. These D0 settings, not exceeding the average beam dose per fraction (approximately 5 Gy for the two-beam plan) in the liver SABR planning, were chosen to ensure activation of the FLASH effect. Besides, the scanning pattern was considered, and a scanning speed of 10 mm/ms, as assumed by the Varian research group,(Folkerts et al 2020) was employed in evaluating the FLASH effective dose.

The clinical benefit of induced by FLASH was assessed by comparing the FLASH dose of IMPT-RF to the dose of an IMPT-CONV plan in the concerned normal tissues, and quantifying the achieved dose reduction. Since tumor cells are deemed unaffected by FLASH, no dose reduction is applied within the gross tumor volume (GTV). In contrast, the margin extending from the GTV to planning target volume (PTV), known as PTV-GTV, is especially intriguing. This region, which potentially comprises both healthy tissue and tumor cells and is exposed to high doses of radiation, may exhibit a clinically relevant differential response if the FLASH effect operates at the cellular level.(Krieger et al 2022) Thus, the clinical benefits of FLASH in PTV-GTV was evaluated, along with its impact on other surrounding normal tissues. Furthermore, the impact of the number of beams on the FLASH effect was assessed by comparing the clinical benefits achieved by FLASH between Case 1, who was treated with two beams, and Cases 2 and 3, each treated with three beams in their FLASH planning.

3. Results

3.1. Analysis of the modularized pin-RFs

The total number of ridge pins in the pin-RFs of an IMPT-RF plan was proportional to the target size, with the highest count of 343 observed in Case 3 and the lowest of 153 in Case 1. A statistical analysis on the step counts per ridge pin revealed significant differences across the cases, with relative frequencies depicted in Figure 3(a) and absolute frequency distributions in Figure S1. All cases featured ridge pins with up to four steps. Specifically, in Case 2, 62% of the pins consisted of three steps, while in Case 3, nearly 97% of the pins had three to four steps. In contrast, 52% of the pins in Case 1 predominantly consisted of two steps. This variation in the number of steps per pin likely stems from differences in modulation complexities due to target size, with Case 3 requiring more complex energy modulation.

Figure 3.

Figure 3.

Frequency distributions for Cases 1 (red), 2 (blue), and 3 (green); (a) Percentage of pins by number of steps per pin, (b) Percentage of steps by WET, (c) Percentage of steps by width, and (d) Percentage of unit modules by width.

Figure 3(b) displays the relative frequency distribution of step WETs across pins for each case, with absolute distributions provided in Figure S1. The total number of steps in the pin-RFs for an IMPT-RF plan increased with target size; Case 1 had the fewest at 340, and Case 3 the most at 1173. Across all cases, step WETs ranged up to 8–9 cm but were predominantly below 3.5 cm, with approximately 78–87% of steps falling within this range. Additionally, the most common WET was 0.5 cm across all cases, accounting for 16% of steps in Case 2 and around 22% of steps in Cases 1 and 3. Such frequent occurrence of thinner steps suggests the need for a fine energy modulation, as thinner steps correspond to smaller energy discrepancies along each PBD. Note that the bottom step of some ridge pins, at 0 cm thickness, corresponded to the highest energy used in IMPT-DS planning. Furthermore, the relative and absolute frequency distributions of step widths across pins for each case were analyzed, as shown in Figures 3(c) and S1. All pins started with a base step width of 6 mm, which was the most common across all cases, matching the total number of pins per case. The proportion of this step width was inversely related to the total step count, peaking at 45% in Case 1. Conversely, step widths of 1 mm and 5 mm were less frequent across all cases, each comprising less than 8%, with 2 mm steps in Case 1 also below 9%.

We conducted an analysis of the demand for unit modules of varying widths required for pin-RF assembly, which involves stacking unit modules corresponding to the widths of steps in each pin. As depicted in Figure 3(d), the demand pattern for unit module widths mirrors the frequency distribution of step widths for each case shown in Figure 3(c). Modules with a width of 6 mm were in the highest demand across all cases, with demand inversely proportional to target size—accounting for 57%, 43%, and 33% of total modules in Cases 1, 2, and 3, respectively. In terms of quantity, Case 3 required the most 6 mm modules (1510), while Case 1 required the fewest (871), as shown in Figure S1. There was also a notable demand for modules with widths of 2 to 4 mm in Cases 2 and 3, and 3 and 4 mm in Case 1, each with a relative frequency ranging from 13% to 19%. The least demanded widths across all cases were 1 and 5 mm, as well as 2 mm for Case 1, each with a relative frequency below 7%. Therefore, this analysis could inform the optimal composition of the module set, primarily featuring unit modules of 6 mm width, supplemented by a balanced selection of modules ranging from 2 to 4 mm in width, and a minimal quantity of modules of widths 1 and 5 mm.

3.2. Dosimetric assessment of FLASH planning

For each case, the translated IMPT-RF plan from the IMPT-DS plan met all dosimetric criteria, with the normalization ensuring that 95% of the CTV received the prescribed dose. The plan quality of the IMPT-DS plan was well preserved by the corresponding IMPT-RF plan. Figure 4 (a) and (b) depict the 2D dose distributions of the IMPT-DS and IMPT-RF plans for Case 1, respectively, serving as an example. The corresponding comparisons for Cases 2 and 3 are illustrated in Figure S2 (a) and (b), and Figure S3 (a) and (b), respectively. Notably, there was a minor increase in the low-dose spillage near the distal edge of the target in the IMPT-RF plan, attributed to the increased spot size/penumbra from the pin-RFs. Additionally, relevant dose indicators of the concerned surrounding normal tissues were derived from the dose volume histograms (DVHs) of both plans across all cases, which are presented in Table S1S3 in the Supplementary Material. CI and D2% of the CTV are also included in Table S1S3. Illustratively, Figure 4 (c) presents the DVHs comparison between the two plans for Case 1.

Figure 4.

Figure 4.

Dosimetric Analysis for Case 1. 2D dose distributions for (a) IMPT-DS and (b) IMPT-RF plans. (c) DVH comparisons between IMPT-DS and IMPT-RF. DVHs of 12 perturbed doses and the nominal dose under range uncertainties of 3.5% and setup uncertainties of (d) 5 mm and (e) 3 mm. The CTV, liver-GTV, duodenum, stomach and skin are contoured in blue, orange, green, purple and pink, respectively. The dose scale in isodose plot ranges from 10% to 110% of the prescription dose.

Overall, good target dose conformity was achieved in the IMPT-DS plans, with CI values ranging from 1.1 to 1.5. The best target dose conformity (CI = 1.1) was observed in Case 3, which had the closest beam arrangement. This conformity was well preserved in the translated IMPT-RF plans, with the CI difference between IMPT-DS and IMPT-RF plans not exceeding 0.1. For target dose homogeneity, D2% of the CTV ranged from 104.6% to 108.6% in the IMPT-DS plans, and from 111.6% to 113% in the translated IMPT-RF plans. Notably, the increase in D2% in the IMPT-RF plans compared to IMPT-DS plans correlated with target size, with the highest increase (8.4%) in Case 3 and the lowest (3.0%) in Case 1. This is likely due to increased scattering from the larger number of ridge pins used for larger targets, leading to greater dose variation between the IMPT-DS and translated IMPT-RF plans. Regarding normal tissue sparing, variations in the dose indicators representing maximum doses for a point or small volume, such as the maximum dose (Dmax) of skin across all cases and D5cc of rib for Case 2, generally remained marginal, not exceeding 2.5 Gy between the two plans. The exception was the Dmax of esophagus for Case 2, which experienced a notable increase of up to 4.3 Gy from the IMPT-DS to the IMPT-RF plan. This significant rise was due to the esophagus being located in a relatively low-dose region, making it more susceptible to the increased low-dose spillage caused by the enlarged spots from the pin-RFs. Besides, the V21Gy of the liver excluding the GTV (liver-GTV), measuring the volume of liver-GTV receiving at least 21 Gy, showed a marginal change (< 3.5%) from IMPT-DS to IMPT-RF across all cases.

Results from the robustness analysis are shown in Figure 4 (d), which features DVHs for both the nominal dose and 12 perturbed doses of the IMPT-DS plan for Case 1, provided as an illustrative example. Figures S2 (d) and S3 (d) show the DVH bands resulting from the robustness analysis for Cases 2 and 3, respectively. We assessed the robustness of the plans by analyzing the D95% of the CTV in the second worst-case scenario. The resulting values were 89%, 96.2%, and 96.5% for Cases 1, 2, and 3, respectively, under setup uncertainties of 5 mm and range uncertainties of 3.5%. These results indicate that the IMPT-DS plans for Cases 2 and 3 demonstrated sufficient robustness, while Case 1 exhibited lower robustness, falling below the 95% threshold. The reduced robustness of the IMPT-DS plan for Case 1 can be attributed to two factors: the use of fewer beams in planning, which compromises robustness of the plan against setup uncertainties, and the deeper location of the target relative to the other cases, which introduces greater range uncertainties. Notably, significant discrepancies between the perturbed and nominal DVHs for the duodenum are evident in Figure 4 (d), attributable to its small volume and proximity to the target. Given that this is a proton FLASH plan, which may benefit from the motion ‘freeze’ effect due to its ultra-fast delivery, it has the potential to allow for a smaller setup uncertainty compared to conventional IMPT plans. Therefore, we evaluated the plan robustness for Case 1 using a reduced setup uncertainty of 3 mm alongside of the range uncertainty of 3.5%. The corresponding DVH bands are illustrated in Figure 4 (e). Under the reduced setup uncertainty, the D95% of the CTV in the second worst-case scenario improved to 95.1%, meeting the clinical acceptance criteria. Hence, the IMPT-DS plan is capable of maintaining adequate target coverage despite the setup and range uncertainties, thereby ensuring the robustness of the translated IMPT-RF plan for FLASH delivery.

3.3. Evaluation of the FLASH effect

The FLASH effect of the IMPT-RF plan with modularized pin-RFs were assessed by comparing the FLASH doses of the IMPT-RF plan at various dose threshold D0 of 5, 3 and 1 Gy, referred to as FLASH-5Gy, FLASH-3Gy, and FLASH-1Gy, respectively, with the dose of the IMPT-RF plan. Figure 5 illustrates the results for Case 1, and the results for the other two are available in Figures S4 and S5 in the Supplementary Material. Additionally, dose indicators for relevant normal structures, including PTV-GTV for all cases, are detailed in Tables S1 to S3.

Figure 5.

Figure 5.

FLASH assessment for Case 1. 2D dose distributions for (a) IMPT-CONV and (b) FLASH-5Gy. (c) DVH comparisons between IMPT-CONV, IMPT-RF and FLASH-5Gy. 2D dose distributions for (d) IMPT-CONV and (e) FLASH-5Gy. (f) DVH comparisons between IMPT-CONV, FLASH-3Gy and FLASH-1Gy. The PTV-GTV, liver-GTV, duodenum, stomach and skin are contoured in blue, orange, green, purple and pink, respectively. The dose scale in isodose plot ranges from 10% to 110% of the prescription dose.

Identical dose distributions were noted between the FLASH-5Gy and the IMPT-RF plans for Cases 2 and 3, as the D0 of 5 Gy exceeded the fractional beam doses in these three-beam plans. With the integration of SFO into the FLASH planning process, each beam in a three-beam plan delivered about 3.3 Gy to the target in each fraction. Consequently, at a D0 of 5 Gy, a FLASH effect could not be initiated for the three-beam plans. In contrast, the FLASH effect was activated for Case 1 of the two-beam plans, leading to a significant 19.8% reduction in Dmean of PTV-GTV and a slight reduction of 6.1% in Dmax of skin. However, despite the Dmax of stomach exceeding 25 Gy (> 5 Gy per fraction), no reduction was observed with FLASH at a D0 of 5 Gy. This was attributed to the anatomical positioning, where the maximum dose occurred at the intersection of two beams, and individual beam doses were insufficient to trigger the FLASH effect, unlike the skin where the maximum dose was delivered along a single beam path.

Lowering D0 to 3 Gy resulted in significant dose reductions for Case 1, with FLASH-3Gy showing decreases from 19.4 to 31.3% in Dmax of skin, V21Gy of liver-GTV, and Dmean of PTV-GTV compared to IMPT-RF. However, for Cases 2 and 3, reductions were limited to 17.2% in these indicators. This diminished FLASH effect in Cases 2 and 3 can be attributed to lower fractional beam doses, which shortened the FLASH triggering windows and resulted in lesser dose reductions. Notably, reductions in these three dose indicators were lower for Case 3 compared to Case 2, with no reductions observed in Dmax of skin and V21Gy of liver-GTV for Case 3. This difference can be attributed to the closer beam arrangements in Case 3, which led to a larger volume of normal tissues at the beam intersections receiving high doses (> 45 Gy). Consequently, the fractional beam doses were either insufficient to trigger FLASH or resulted in less FLASH effect for Case 3. Similar trend was noted in other dose indicators across the cases, highlighting that delivering a high fractional beam dose to a specific area is essential for activating the FLASH effect in the normal tissues within that region.

Reducing D0 from 3 to 1 Gy led to significant reductions in dose indicators across the cases: 8.6 to 24.1% in V21Gy of liver-GTV in Case 1, Dmax of great vessels in Case 2, and Dmax of duodenum, skin, and D0.5cc of bowel bag in Case 3, comparing FLASH-3Gy to FLASH-1Gy. However, minimal or no reductions—less than 5%—were seen in other dose indicators when lowering D0 from 3 to 1 Gy, such as the unchanged Dmax of skin for Case 2, as illustrated in Figure S6 of the Supplementary Material. Although some dose reductions in skin from FLASH-3Gy to FLASH-1Gy for Case 2 were observed, certain areas receiving significant beam doses showed no reduction. This could be due to the accumulation of doses from multiple spot deliveries, resulting in an insufficient dose rate to trigger the FLASH effect.

3.4. Clinical benefits brought by FLASH

Comparisons between the FLASH doses and the reference doses from the IMPT-CONV plan were conducted to evaluate the clinical advantages of FLASH across various cases. Results for Case 1 are visually depicted in Figure 5, while results for Cases 2 and 3 are available in Figures S4 and S5 in the Supplementary Material. Dose indicators for normal structures related to the IMPT-CONV plans are detailed in Tables S1S3. Since no FLASH effect was obtained at D0 of 5 Gy for Cases 2 and 3, these comparisons were excluded. Comparing FLASH-5Gy to IMPT-CONV for Case 1, a significant reduction of 19.5% in Dmean of PTV-GTV was observed, suggesting a positive clinical benefit on potential normal tissues in this region. Conversely, other dose indicators experienced increases of up to 17.8%, with V21Gy of liver-GTV showing the highest increase, indicating negative clinical benefits induced to these normal tissues by the FLASH plan.

Lowering D0 to 3 Gy for Case 1 resulted in enhanced clinical benefits, notably achieving a substantial 31.0% reduction in Dmean of PTV-GTV in FLASH-3Gy compared to IMPT-CONV. Positive clinical benefits were observed across most normal tissues, with only a slight 2.3% increase in Dmax of the stomach noted. Particularly, this adjustment reversed the negative clinical impact previously seen in liver-GTV at D0 of 5 Gy, resulting in a positive clinical benefit with a 5.1% reduction. In contrast, Case 2 and 3 showed reductions of only 14.9% and 4.1% in Dmean of PTV-GTV, respectively, along with a slight reduction of < 2.8% in Dmax of rib for Case 2, and Dmax of duodenum and D0.5cc of the bowel bag for Case 3. Negative clinical benefits were observed in other normal tissues when comparing FLASH-3Gy to IMPT-CONV for these two cases. As mentioned earlier, this discrepancy in clinical benefit compared to Case 1 could result from the reduced fractional beam doses due to additional beam or closer beam arrangement. This effect may be amplified in regions experiencing low-dose spillage due to enlarged spots in FLASH plan delivery, potentially leading to significant negative clinical benefits. For example, an increase of up to 5.5 Gy in Dmax of the esophagus was observed for Case 2.

At D0 of 1 Gy, Case 1 showed positive clinical benefits across all concerned normal tissues, with reductions in relevant dose indicators ranging from 2.7% to 31.2% when comparing FLASH-1Gy to IMPT-CONV. Conversely, Cases 2 and 3 displayed negative clinical benefits on certain normal tissues. For example, there were increases of 17.4% in the maximum skin dose for Case 2 and of 7.4% in the liver-GTV V21Gy for Case 3. It is noteworthy that reducing D0 from 3 to 1 Gy still led to some significant negative clinical benefits, such as the significant increase in Dmax of esophagus for Case 2 remained unchanged. However, drastically enhanced clinical benefits were obtained for Case 3, including a reduction of around 18% in Dmax of duodenum and D0.5cc of the bowel bag when comparing FLASH-1Gy to IMPT-CONV. Normal tissues subjected to high fractional beam doses, such as the bowel bag in Case 3, or situated in high-dose regions minimally impacted by the low-dose spillage from enlarged spots in FLASH plan delivery—for example, PTV-GTV of all cases and the duodenum of Case 3—tend to have extended FLASH triggering windows with reduced D0. These tissues generally gain more from the FLASH effect with reduced D0, leading to either positive or minimally negative clinical outcomes. These tissues typically gain more from the FLASH effect, resulting in positive or minimal negative clinical benefits.

4. Discussion

In this study, we validated the concept of modularizing streamlined pin-RFs within a single-energy proton FLASH planning framework for liver SABR. While the pin-RFs developed using our framework are characterized by a coarser resolution and fewer steps along each ridge pin than existing pin-RF designs(Liu et al 2023, Zhang et al 2022a)—an attribute that already simplifies the production process, including 3D printing—the modularization technique we have introduced further refines production efficiency. By modularizing these pin-RFs, we have established a more streamlined manufacturing approach through the assembly of fixed-size modules from a pre-defined set. These reusable modules could not only reduce the production cost, but also facilitate easy modifications of the pin-RFs during the treatment. Moreover, we adopted graphite for range shifters due to its higher RSP and lower MCS effect compared to PMMA, potentially enabling smaller proton spot sizes and thus enhancing the dose conformity of the single-energy FLASH plan.

Our analysis of modularized pin-RFs demonstrated a primary demand for modules of 6 mm widths, followed by 2 to 4 mm widths, with minimal need for 1- and 5-mm modules. This distribution informs an optimal module set composition. Furthermore, our findings revealed a correlation between the complexity of energy modulation in IMPT-RF planning and factors such as target size. Larger targets, as illustrated in Case 3, required a greater number of ridge pins and steps, exhibiting more complex energy modulation. Additionally, the frequent occurrence of thinner steps across all cases suggests the need for a fine energy modulation to achieve optimal dose distribution in IMPT-RF planning. Thus, extending the application of this method to additional cases and varied treatment sites could further refine our understanding of modularized pin-RFs and lead to a more optimal configuration of unit modules for the predefined set. Besides, our FLASH planning framework enables the adjustment of parameters, including energy layer spacing and the criteria for spot removal in the spot reduction process during IMPT-DS planning. This flexibility allows for the fine-tuning of pin and step counts, thus facilitating the customization of the resolution of the pin-RFs. Consequently, it opens the possibility for exploring unit modules of various sizes and resolutions, enhancing the assembly process of pin-RFs.

It should be noted that water was employed in this study to simulate the unit modules for pin-RF assembly, selected for its compatibility with the highest available resolution for dose calculation in RayStation 10B, which is 1 mm voxel size. This resolution allows module thicknesses to precisely match the required WETs in integer mm, ensuring alignment with the dose grid when assembling pin-RFs. This alignment is crucial for maintaining desired pin-RF shapes and achieving accurate dose calculations. Notably, materials with a low atomic number and minimal MCS effects are preferred for range shifters to enhance FLASH plan quality, a principle applicable to pin-RFs as well. To optimize the quality of FLASH plans, it is beneficial to explore alternative materials, along with adjusting sizes and resolutions of the unit modules for pin-RF assembly. Such investigations can be conducted by advanced Monte Carlo dose calculation tools (e.g., Geant4) allowing high resolution simulations and can be further supported by experimental measurements.

The FLASH doses in single-energy IMPT-RF plans were assessed using a phenomenological FLASH effectiveness model. This model integrates considerations of the dose threshold, FLASH persistence, and the dose rate threshold necessary for FLASH activation, providing a comprehensive reflection of the FLASH effect. The quantification of FLASH effects across all cases, in terms of physical dose reductions and clinical benefits at various dose thresholds for FLASH triggering, confirmed the strong correlations between dose threshold and the FLASH effect as previously demonstrated. These findings further provide insights into how the FLASH effect correlates with factors such as beam dose, beam arrangement, and the location of normal tissues. Notably, lower fractional beam doses necessitate a reduced dose threshold for FLASH triggering, typically resulting in a diminished FLASH effect. This pattern is evident in Cases 2 and 3, which involve three beams, compared to Case 1 with two beams. Additionally, closer beam arrangements, observed in Case 3, lead to decreased fractional beam doses, subsequently reducing the FLASH effect. The employment of more beams, particularly with additional pin-RFs incorporated in FLASH planning, increases low-dose exposure, causing more extensive low-dose spillage. Consequently, normal tissues located in areas exposed to this spillage often exhibit reduced benefits from the FLASH effect and may even experience negative clinical benefits. It is crucial to recognize that lowering the dose threshold to zero does not enable full dose delivery as FLASH to all normal tissue voxels, especially those receiving doses from multiple spot deliveries, due to the insufficient dose rate for FLASH trigger under these conditions.

Based on the correlations revealed between the FLASH effect and factors such as beam dose, beam arrangement, and the location of normal tissues, several considerations are essential in planning to maximize the FLASH effect. First, protocols that prescribe large fractional doses are essential, as they ensure the high fractional beam doses needed for a significant FLASH effect. Second, it is vital to minimize the number of beams while still ensuring adequate target dose coverage and sparing of normal tissues, in order to maintain substantial fractional beam doses. Third, reducing beam intersections beyond the target area, where feasible, can help increase spot doses critical for triggering the FLASH effect. Besides, normal tissues affected by low-dose spillage would benefit from a narrower beam penumbra, achievable through the use of collimators in conjunction with range shifters. Further applications of our FLASH planning method across various cases and treatment sites are necessary to refine and validate these strategies.

In setting machine parameters, the 500 nA beam current used in our study is based on data from the Paul Scherrer Institute (PSI) cyclotron, which shares the same superconductive accelerator and beam transport system as the Varian ProBeam. Under clinical conditions, the PSI cyclotron routinely extracts proton beams up to 800 nA (Nesteruk et al 2021, Geisler et al 2007). Therefore, we selected a high beam current of 500 nA for our study, which is below the maximum clinically achievable current for this type of cyclotron, to ensure a sufficient dose rate for pencil beam delivery to achieve the FLASH effect. However, the current FLASH-enabled Varian ProBeam system is limited to a beam current about 220 nA and may not yet support such high beam currents. Additionally, with a high beam current, a relatively high minimum spot MU is required to ensure plan deliverability, potentially degrading plan quality. Conversely, reducing the minimum spot time (MST) allows for a lower minimum MU per spot in planning without compromising FLASH coverage. This was validated in a study (Wei et al 2022a) investigating the impact of MST values of 2 ms and 0.5 ms for the Varian ProBeam on the FLASH effect. Based on these findings, we used an MST of 0.5 ms in our study to accommodate a minimum spot MU of 300, balancing FLASH dose coverage and plan quality at a high beam current of 500 nA. However, achieving an MST of 0.5 ms may not be feasible with the current FLASH-enabled Varian ProBeam, which is constrained to an MST of 2–3 ms. Given this limitation, further investigation is needed to explore (1) increasing the minimum spot MU at high beam currents, like 500 nA, for FLASH planning, or (2) lowering the beam current to maintain the current minimum spot MU without compromising FLASH dose coverage.

To wrap up, it is important to highlight the potential of the motion ‘freeze’ effect achieved through the ultra-fast delivery of FLASH-RT in future proton FLASH planning. In conventional IMPT planning, particularly for areas with significant motion, such as the liver, large target margins or 4D motion-robust optimization techniques are often required to manage free-breathing scenarios, leading to increased exposure of healthy tissues. Additionally, motion management strategies like gating or tracking can introduce residual uncertainties. By leveraging the motion ‘freeze’ effect of FLASH-RT, proton FLASH planning could benefit from smaller target margins and more flexible optimization strategies, such as multi-field optimization, ultimately enhancing normal tissue sparing. Additionally, this effect enables the implementation of pencil beam scan-pattern optimization in proton FLASH planning. Since the local FLASH effect is influenced by the spatiotemporal structure of dose delivery, a study on proton FLASH-RT shows that optimized patterns, which prioritize the consecutive delivery of nearby pencil beams in the transverse plane, consistently achieve higher FLASH coverage at low beam currents (José Santo et al 2023). Incorporating such scan-pattern optimization in our proton FLASH planning could further enhance the FLASH effect and improve plan quality by utilizing lower beam currents, potentially addressing the challenges associated with achieving high beam currents and low minimum spot times due to current technological constraints.

5. Conclusions

In this study, we demonstrated the feasibility of modularizing the streamlined pin-RFs in single-energy proton FLASH planning for liver SABR. Our analysis of modularized pin-RFs provides guidance on the optimal composition of the module set. Additionally, our findings from quantifying FLASH effects across clinical cases offer valuable insights into the relationships between the FLASH effect and factors such as beam dose, beam arrangement, and the location of normal tissues. These insights are critical for enhancing planning strategies to maximize the FLASH effect. It is crucial to apply the proposed method to additional cases and varied treatment sites to optimize the configuration of the unit module set for enhance pin-RF assembly and to refine planning strategies to maximize the FLASH effect.

Supplementary Material

pmbad95d6supp1.pdf

Acknowledgment

This research is supported in part by the National Institutes of Health under Award Number R01CA272991, R56EB033332, R01EB032680, and U54CA274513.

Footnotes

Conflicts of interest

The authors have no conflicts to disclose.

Ethical Statement. Emory IRB review board approval was obtained (IRB #114349), and informed consent was not required for this Health Insurance Portability and Accountability Act (HIPAA) compliant retrospective analysis. This study was performed in accordance with the Declaration of Helsinki and in accordance with the local statutory requirements.

Reference

  1. Anon Irradiation of Melanoma in a Pulse (IMPulse) Online: https://classic.clinicaltrials.gov/ct2/show/study/NCT04986696
  2. Bourhis J, Montay-Gruel P, Gonçalves Jorge P, Bailat C, Petit B, Ollivier J, Jeanneret-Sozzi W, Ozsahin M, Bochud F, Moeckli R, Germond JF and Vozenin MC 2019a. Clinical translation of FLASH radiotherapy: Why and how? Radiotherapy and Oncology 139 11–7 [DOI] [PubMed] [Google Scholar]
  3. Bourhis J, Sozzi WJ, Jorge PG, Gaide O, Bailat C, Duclos F, Patin D, Ozsahin M, Bochud F, Germond JF, Moeckli R and Vozenin MC 2019b. Treatment of a first patient with FLASH-radiotherapy Radiotherapy and Oncology 139 18–22 [DOI] [PubMed] [Google Scholar]
  4. Daugherty EC, Mascia A, Zhang Y, Lee E, Xiao Z, Sertorio M, Woo J, McCann C, Russell K, Levine L, Sharma R, Khuntia D, Bradley J, Simone CB II, Perentesis J and Breneman J 2023. FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study JMIR Res Protoc 12 e41812 Online: https://www.researchprotocols.org/2023/1/e41812 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daugherty E, Zhang Y, Xiao Z, Mascia A, Sertorio M, Woo J, McCann C, Russell K, Sharma R, Khuntia D, Bradley J, Simone C, Breneman J and Perentesis J 2024. FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach Radiation Oncology 19 34 Online: https://ro-journal.biomedcentral.com/articles/10.1186/s13014-024-02419-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Favaudon V, Caplier L, Monceau V, Pouzoulet F, Sayarath M, Fouillade C, Poupon M-F, Brito I, Hupé P, Bourhis J, Hall J, Fontaine J-J and Vozenin M-C 2014. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice Online: https://www.science.org/doi/10.1126/scitranslmed.3008973 [DOI] [PubMed]
  7. Folkerts MM, Abel E, Busold S, Perez JR, Krishnamurthi V and Ling CC 2020. A framework for defining FLASH dose rate for pencil beam scanning Med Phys 47 6396–404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fouillade C, Curras-Alonso S, Giuranno L, Quelennec E, Heinrich S, Bonnet-Boissinot S, Beddok A, Leboucher S, Karakurt HU, Bohec M, Baulande S, Vooijs M, Verrelle P, Dutreix M, Londoño-Vallejo A and Favaudon V 2020. FLASH irradiation spares lung progenitor cells and limits the incidence of radio-induced senescence Clinical Cancer Research 26 1497–506 [DOI] [PubMed] [Google Scholar]
  9. Gao H, Lin B, Lin Y, Fu S, Langen K, Liu T and Bradley J 2020. Simultaneous dose and dose rate optimization (SDDRO) for FLASH proton therapy Med Phys 47 6388–95 Online: https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.14531 [DOI] [PubMed] [Google Scholar]
  10. Geisler AE, Hottenbacher J, Klein HU, Krischel D, Röcken H, Schillo M, Stephani T, Timmer JH and Baumgarten C 2007. Commissioning of the ACCEL 250 MEV proton cyclotron Proceedings of the 18th International Conference on Cyclotrons and Their Applications 2007, CYCLOTRONS 2007 9–14 Online: https://accelconf.web.cern.ch/c07/papers/9.pdf [Google Scholar]
  11. Jolly S, Owen H, Schippers M and Welsch C 2020. Technical challenges for FLASH proton therapy Physica Medica 78 71–82 [DOI] [PubMed] [Google Scholar]
  12. José Santo R, Habraken SJM, Breedveld S and Hoogeman MS 2023. Pencil-beam Delivery Pattern Optimization Increases Dose Rate for Stereotactic FLASH Proton Therapy Int J Radiat Oncol Biol Phys 115 759–67 [DOI] [PubMed] [Google Scholar]
  13. Kang M, Wei S, Choi JI, Lin H and Simone CB 2022. A Universal Range Shifter and Range Compensator Can Enable Proton Pencil Beam Scanning Single-Energy Bragg Peak FLASH-RT Treatment Using Current Commercially Available Proton Systems Int J Radiat Oncol Biol Phys 113 203–13 Online: 10.1016/j.ijrobp.2022.01.009 [DOI] [PubMed] [Google Scholar]
  14. Krieger M, van de Water S, Folkerts MM, Mazal A, Fabiano S, Bizzocchi N, Weber DC, Safai S and Lomax AJ 2022. A quantitative FLASH effectiveness model to reveal potentials and pitfalls of high dose rate proton therapy Med Phys 49 2026–38 Online: https://onlinelibrary.wiley.com/doi/10.1002/mp.15459 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Levy K, Natarajan S, Wang J, Chow S, Eggold JT, Loo PE, Manjappa R, Melemenidis S, Lartey FM, Schüler E, Skinner L, Rafat M, Ko R, Kim A, Al-Rawi D H, von Eyben R, Dorigo O, Casey KM, Graves EE, Bush K, Yu AS, Koong AC, Maxim PG, Loo BW and Rankin EB 2020. Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice Sci Rep 10 1–14 Online: 10.1038/s41598-020-78017-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lin Y, Lin B, Fu S, Folkerts MM, Abel E, Bradley J and Gao H 2021. SDDRO-joint: simultaneous dose and dose rate optimization with the joint use of transmission beams and Bragg peaks for FLASH proton therapy Phys Med Biol 66 125011 Online: https://iopscience.iop.org/article/10.1088/1361-6560/ac02d8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Liu R, Charyyev S, Wahl N, Liu W, Kang M, Zhou J, Yang X, Baltazar F, Palkowitsch M, Higgins K, Dynan W, Bradley J and Lin L 2023. An Integrated Physical Optimization Framework for Proton Stereotactic Body Radiation Therapy FLASH Treatment Planning Allows Dose, Dose Rate, and Linear Energy Transfer Optimization Using Patient-Specific Ridge Filters International Journal of Radiation Oncology*Biology*Physics 1–29 Online: https://linkinghub.elsevier.com/retrieve/pii/S0360301623000974 [DOI] [PubMed] [Google Scholar]
  18. Loo BW, Schuler E, Lartey FM, Rafat M, King GJ, Trovati S, Koong AC and Maxim PG 2017. (P003) Delivery of Ultra-Rapid Flash Radiation Therapy and Demonstration of Normal Tissue Sparing After Abdominal Irradiation of Mice International Journal of Radiation Oncology*Biology*Physics 98 E16 Online: [Google Scholar]
  19. Ma C, Yang X, Chang C, Liu R, Bohannon D, Lin L, Liu T, Tian S and Zhou J 2023. Feasibility study of hybrid inverse planning with transmission beams and single-energy spread-out Bragg peaks for proton FLASH radiotherapy Med Phys 50 3687–700 Online: https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.16370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ma C, Zhou J, Chang C, Wang Y, Patel PR, Yu DS, Tian S and Yang X 2024. Streamlined pin-ridge-filter design for single-energy proton FLASH planning Med Phys 51 2955–66 Online: https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.16939 [DOI] [PubMed] [Google Scholar]
  21. van Marlen P, Dahele M, Folkerts M, Abel E, Slotman BJ and Verbakel WFAR 2020. Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams Int J Radiat Oncol Biol Phys 106 621–9 Online: 10.1016/j.ijrobp.2019.11.011 [DOI] [PubMed] [Google Scholar]
  22. Mascia AE, Daugherty EC, Zhang Y, Lee E, Xiao Z, Sertorio M, Woo J, Backus LR, McDonald JM, McCann C, Russell K, Levine L, Sharma RA, Khuntia D, Bradley JD, Simone CB, Perentesis JP and Breneman JC 2023. Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial JAMA Oncol 9 62–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mazal A, Prezado Y, Ares C, De Marzi L, Patriarca A, Miralbell R and Favaudon V 2020. FLASH and minibeams in radiation therapy: The effect of microstructures on time and space and their potential application to protontherapy British Journal of Radiology 93 1–17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Montay-Gruel P, Acharya MM, Petersson K, Alikhani L, Yakkala C, Allen BD, Ollivier J, Petit B, Jorge PG, Syage AR, Nguyen TA, Baddour AAD, Lu C, Singh P, Moeckli R, Bochud F, Germond JF, Froidevaux P, Bailat C, Bourhis J, Vozenin MC and Limoli CL 2019. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species Proc Natl Acad Sci U S A 166 10943–51 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Montay-Gruel P, Petersson K, Jaccard M, Boivin G, Germond JF, Petit B, Doenlen R, Favaudon V, Bochud F, Bailat C, Bourhis J and Vozenin MC 2017. Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s Radiotherapy and Oncology 124 365–9 [DOI] [PubMed] [Google Scholar]
  26. Nabavizadeh N, Waller JG, Fain R, Chen Y, Degnin CR, Elliott DA, Mullins BT, Patel IA, Dyer BA, Fakhoury K, Naugler WE, Farsad K, Tanyi JA, Fuss M, Thomas CR and Hung AY 2018. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment Int J Radiat Oncol Biol Phys 100 577–85 Online: 10.1016/j.ijrobp.2017.11.030 [DOI] [PubMed] [Google Scholar]
  27. Nesteruk KP, Togno M, Grossmann M, Lomax AJ, Weber DC, Schippers JM, Safai S, Meer D and Psoroulas S 2021. Commissioning of a clinical pencil beam scanning proton therapy unit for ultra-high dose rates (FLASH) Med Phys 48 4017–26 [DOI] [PubMed] [Google Scholar]
  28. Newhauser WD and Zhang R 2015. The physics of proton therapy Phys Med Biol 60 R155–209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Psoroulas S, Meer D, Oponowicz E and Owen H 2020. Mean excitation energy determination for Monte Carlo simulations of boron carbide as degrader material for proton therapy Physica Medica 80 111–8 Online: 10.1016/j.ejmp.2020.09.017 [DOI] [PubMed] [Google Scholar]
  30. Schwarz M, Traneus E, Safai S, Kolano A and van de Water S 2022. Treatment planning for Flash radiotherapy: General aspects and applications to proton beams Med Phys 49 2861–74 [DOI] [PubMed] [Google Scholar]
  31. Simeonov Y, Weber U, Penchev P, Ringbæk TP, Schuy C, Brons S, Engenhart-Cabillic R, Bliedtner J and Zink K 2017. 3D range-modulator for scanned particle therapy: development, Monte Carlo simulations and experimental evaluation Phys Med Biol 62 7075–96 Online: https://iopscience.iop.org/article/10.1088/1361-6560/aa87f5 [DOI] [PubMed] [Google Scholar]
  32. Spitz DR, Buettner GR, Petronek MS, St-Aubin JJ, Flynn RT, Waldron TJ and Limoli CL 2019. An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses Radiotherapy and Oncology 139 23–7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vozenin MC, De Fornel P, Petersson K, Favaudon V, Jaccard M, Germond JF, Petit B, Burki M, Ferrand G, Patin D, Bouchaab H, Ozsahin M, Bochud F, Bailat C, Devauchelle P and Bourhis J 2019. The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients Clinical Cancer Research 25 35–42 [DOI] [PubMed] [Google Scholar]
  34. van de Water S, Safai S, Schippers JM, Weber DC and Lomax AJ 2019. Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates Acta Oncol (Madr) 58 1463–9 [DOI] [PubMed] [Google Scholar]
  35. Wei S, Lin H, Choi JI, Press RH, Lazarev S, Kabarriti R, Hajj C, Hasan S, Chhabra AM, Simone CB and Kang M 2022a. FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification Front Oncol 11 1–11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wei S, Lin H, Isabelle Choi J, Shi C, Simone CB and Kang M 2022b. Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional multiple-energy proton PBS techniques Radiotherapy and Oncology 175 238–47 Online: 10.1016/j.radonc.2022.08.005 [DOI] [PubMed] [Google Scholar]
  37. Wei S, Lin H, Shi C, Xiong W, Chen CC, Huang S, Press RH, Hasan S, Chhabra AM, Choi JI, Simone CB and Kang M 2022c. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy Med Phys 49 6560–74 Online: https://onlinelibrary.wiley.com/doi/10.1002/mp.15894 [DOI] [PubMed] [Google Scholar]
  38. Wilson JD, Hammond EM, Higgins GS and Petersson K 2020. Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool’s Gold? Front Oncol 9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zhang G, Gao W and Peng H 2022a. Design of static and dynamic ridge filters for FLASH–IMPT: A simulation study Med Phys 1–13 [DOI] [PubMed] [Google Scholar]
  40. Zhang G, Gao W and Peng H 2022b. Design of static and dynamic ridge filters for FLASH–IMPT: A simulation study Med Phys 49 5387–99 Online: https://onlinelibrary.wiley.com/doi/10.1002/mp.15717 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

pmbad95d6supp1.pdf

RESOURCES